Back to results
US 7,247,706 B2Granted
Double mutant alpha-7 nicotinic acetylcholine receptors
AssigneePharmacia & Upjohn Company
InventorsVincent E. Groppi, Jr., Mitchell B. Berkenpas
Life of this patent
Estimating the term…
Abstract
The invention relates ton novel methods for measuring ion channel transmission and methods and compositions useful in the indentification of ligand gated channel agonists and modulators.
Claims4
An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO:
- 14, wherein:
- (1) either the proline residue at position 230 has been replaced with an amino acid residue selected from the group consisting of glycine, alanine, isoleucine, leucine, and valine, or the serine residue present at position 241 has been replaced with an amino acid residue selected from the group consisting of threonine, methionine, asparagine, glutamine, and tyrosine;
- or
- (2) both the proline residue at position 230 has been replaced with an amino acid residue selected from the group consisting of glycine, alanine, isoleucine, leucine, and valine, and the serine residue present at position 241 has been replaced with an amino acid residue selected from the group consisting of threonine, methionine, asparagine, glutamine, and tyrosine,
- and wherein said polypeptide, when produced in a recombinant SH-EP1 cell that contains an encoding DNA sequence for said polypeptide, evidences increased intracellular calcium accumulation in the presence of nicotine as agonist.
2 more elements
An isolated polypeptide comprising residues 23 through 502 of SEQ ID NO:
- 14, wherein:
- (1) either the proline residue at position 230 has been replaced with an amino acid residue selected from the group consisting of glycine, alanine, isoleucine, leucine, and valine, or the serine residue present at position 241 has been replaced with an amino acid residue selected from the group consisting of threonine, methionine, asparagine, glutamine, and tyrosine;
- or
- (2) both the proline residue at position 230 has been replaced with an amino acid residue selected from the group consisting of glycine, alanine, isoleucine, leucine, and valine, and the serine residue present at position 241 has been replaced with an amino acid residue selected from the group consisting of threonine, methionine, asparagine, glutamine, and tyrosine,
- and wherein said polypeptide, when produced in a recombinant SH-EP1 cell that contains an encoding DNA sequence for said polypeptide, evidences increased intracellular calcium accumulation in the presence of nicotine as agonist.
2 more elements
Dependencies are inferred from the claim text.